Learn about ACTEMRA® treatment for rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis. Find instructions for ACTEMRA® (tocilizumab) subcutaneous injections and helpful information on the ACTEMRA® Medication Guide that should help you better. Inside this kit you’ll also find: .. Some patients may be eligible for free drug through the .. Use a quick, dart-like motion to insert the needle all the way into.
|Published (Last):||15 October 2014|
|PDF File Size:||9.52 Mb|
|ePub File Size:||10.63 Mb|
|Price:||Free* [*Free Regsitration Required]|
Contact immediately, as well as your healthcare provider or nurse, if you experience any of these reactions: This can make you more likely to get infections or make any current infection worse.
In the 6-month control period, in SC-I, the frequency of injection-site reactions was These elevations did not result in apparent permanent or clinically evident hepatic injury in clinical trials.
Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. Once you insrrt ready or your caregiver is ready to inject at home, the video below may help you get started. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.
Tell your healthcare provider if you have these or any other side effect that bothers you or does not go away:. Click “OK” if you are a healthcare professional.
To learn more, call or talk to your healthcare provider to register. Thanks for sharing this page. Neutrophils are white blood cells that help the body fight infection low platelet count.
A total of Infection signs, with or without a fever, include: The link you have selected will indert you away from this site to one that is not owned or controlled by Genentech, Inc. One of these events, urticaria, was considered serious. Your healthcare provider should test you for hepatitis B before starting treatment.
Bacterial, viral and other infections due to opportunistic pathogens. Insdrt you had hives, a rash, or experienced flushing after injecting, you should tell your healthcare provider or nurse before your next injection. In PJIA patients, infusion-related reactions are defined as all events occurring during or within 24 hours of an infusion.
Infection signs, with or without a fever, include: Serious allergic reactions, including death, can happen with ACTEMRA infusions or injections, even if they did acremra occur with an earlier infusion or injection.
The most common ISRs were erythema, pruritus, pain, and swelling at the injection site. Anaphylaxis and other hypersensitivity reactions that required treatment discontinuation were reported in 0.
The most common events actrmra were nasopharyngitis and upper respiratory tract infections. The majority of ISRs reported were Grade 1 events and all ISRs reported were non-serious and none required patient withdrawal from treatment or dose interruption.
Serious allergic reactions Serious allergic reactions, including death, can happen with ACTEMRA infusions or injections, even if they did ineert occur with an earlier infusion or injection. Upper respiratory tract infections like common cold and sinus infections.
Patient Education and Training
You may also call Genentech at Some people have serious infections while taking ACTEMRA, including tuberculosis TBand infections caused by bacteria, fungi, or viruses that can spread throughout the body.
The most common events occurring during infusion were headache, nausea and hypotension, and occurring within 24 hours of infusion were dizziness and hypotension. You may also have changes in other laboratory tests, such as your blood cholesterol levels.
Laboratory monitoring is recommended due to potential consequences of treatment-related laboratory abnormalities in neutrophils, platelets, lipids, and liver function tests. Patients with invasive actemda infections may present with disseminated, rather than localized, packagw.
The impact of treatment with ACTEMRA on demyelinating disorders is not known, but multiple sclerosis and chronic inflammatory inaert polyneuropathy were reported rarely in clinical studies.
Moderate to Severe Rheumatoid Arthritis.
Subcutaneous Injections for RA | ACTEMRA® (tocilizumab)
These ISRs occurred in a greater proportion of patients at or above 30 kg The majority resolved without any treatment and none necessitated drug discontinuation. The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic iinsert recurrent infection. You may also call Genentech at Tell your healthcare provider if you have these or any other side effect that bothers you or does not go away: The most commonly reported serious infections included pneumonia, gastroenteritis, varicella, and otitis media.
Physicians are encouraged to register patients and pregnant women are encouraged to register themselves by calling Tell your healthcare provider right away if you see any signs of these acttemra ACTEMRA is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients pacoage years of age and older.
In the open-label extension over an average duration of 73 weeks of treatment, the overall rate of infections was per imsert. In the open-label extension over an average duration of 73 weeks of treatment, the overall rate of serious infections was Inert parts include the Ohio and Mississippi River Valleys and the Southwest Hepatitis B or have had hepatitis B Be sure to contact your healthcare provider or nurse if you see any signs of these side effects.
Promptly evaluate patients presenting with new-onset abdominal symptoms for early identification of GI perforation.